These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

243 related items for PubMed ID: 21700755

  • 21. Trimetazidine, a metabolic modulator, has cardiac and extracardiac benefits in idiopathic dilated cardiomyopathy.
    Tuunanen H, Engblom E, Naum A, Någren K, Scheinin M, Hesse B, Juhani Airaksinen KE, Nuutila P, Iozzo P, Ukkonen H, Opie LH, Knuuti J.
    Circulation; 2008 Sep 16; 118(12):1250-8. PubMed ID: 18765391
    [Abstract] [Full Text] [Related]

  • 22. Additional use of trimetazidine in patients with chronic heart failure: a meta-analysis.
    Zhang L, Lu Y, Jiang H, Zhang L, Sun A, Zou Y, Ge J.
    J Am Coll Cardiol; 2012 Mar 06; 59(10):913-22. PubMed ID: 22381427
    [Abstract] [Full Text] [Related]

  • 23. The effects of chronic trimetazidine treatment on mechanical function and fatty acid oxidation in diabetic rat hearts.
    Onay-Besikci A, Guner S, Arioglu E, Ozakca I, Ozcelikay AT, Altan VM.
    Can J Physiol Pharmacol; 2007 May 06; 85(5):527-35. PubMed ID: 17632588
    [Abstract] [Full Text] [Related]

  • 24. Trimetazidine: a meta-analysis of randomised controlled trials in heart failure.
    Gao D, Ning N, Niu X, Hao G, Meng Z.
    Heart; 2011 Feb 06; 97(4):278-86. PubMed ID: 21134903
    [Abstract] [Full Text] [Related]

  • 25. Metabolic therapy for patients with diabetes mellitus and coronary artery disease.
    Rosano GM, Vitale C, Fragasso G.
    Am J Cardiol; 2006 Sep 04; 98(5A):14J-18J. PubMed ID: 16931201
    [Abstract] [Full Text] [Related]

  • 26. Beneficial effects of trimetazidine in ex vivo working ischemic hearts are due to a stimulation of glucose oxidation secondary to inhibition of long-chain 3-ketoacyl coenzyme a thiolase.
    Lopaschuk GD, Barr R, Thomas PD, Dyck JR.
    Circ Res; 2003 Aug 08; 93(3):e33-7. PubMed ID: 12869392
    [Abstract] [Full Text] [Related]

  • 27. The effects of trimetazidine on p-wave duration and dispersion in heart failure patients.
    Gunes Y, Tuncer M, Guntekin U, Akdag S, Gumrukcuoglu HA.
    Pacing Clin Electrophysiol; 2009 Feb 08; 32(2):239-44. PubMed ID: 19170914
    [Abstract] [Full Text] [Related]

  • 28. [Energy metabolism in patients with severe chronic viral hepatitis].
    Meng QH, Yu HW, Feng YM, Li XM, Yu SQ, Li YX, Ni MM, Wang JH, Wang H, Liu Y.
    Zhonghua Yi Xue Za Zhi; 2007 Nov 13; 87(42):2982-5. PubMed ID: 18261330
    [Abstract] [Full Text] [Related]

  • 29. [The effects of trimetazidine on left ventricular function and physical exercise tolerance in patients with ischemic cardiomyopathy].
    Sisakian AS, Torgomian AL, Barkhudarian AL.
    Klin Med (Mosk); 2006 Nov 13; 84(10):55-8. PubMed ID: 17201276
    [Abstract] [Full Text] [Related]

  • 30. [Therapeutic value of trimetazidine in patients with coronary heart disease and left ventricular dysfunction].
    Multicentral Collaborative Group on Trimetazidine (Phase IV).
    Zhonghua Xin Xue Guan Bing Za Zhi; 2005 Sep 13; 33(9):793-5. PubMed ID: 16266453
    [Abstract] [Full Text] [Related]

  • 31. Cardiac resynchronization therapy in patients with systolic left ventricular dysfunction and symptoms of mild heart failure secondary to ischemic or nonischemic cardiomyopathy.
    Bleeker GB, Schalij MJ, Holman ER, Steendijk P, van der Wall EE, Bax JJ.
    Am J Cardiol; 2006 Jul 15; 98(2):230-5. PubMed ID: 16828599
    [Abstract] [Full Text] [Related]

  • 32. Early administration of trimetazidine may prevent or ameliorate diabetic cardiomyopathy.
    Wenmeng W, Qizhu T.
    Med Hypotheses; 2011 Feb 15; 76(2):181-3. PubMed ID: 20932648
    [Abstract] [Full Text] [Related]

  • 33. [Clinicopathogenetic features of coronary heart disease combined with chronic obstructive pulmonary diseases and efficiency of therapy with trimetazidin].
    Kolomoets NM, Baksheev VI, Uvaĭsova KU.
    Klin Med (Mosk); 2008 Feb 15; 86(6):38-43. PubMed ID: 18720710
    [Abstract] [Full Text] [Related]

  • 34. Beneficial electrophysiological effects of trimetazidine in patients with postischemic chronic heart failure.
    Cera M, Salerno A, Fragasso G, Montanaro C, Gardini C, Marinosci G, Arioli F, Spoladore R, Facchini A, Godino C, Margonato A.
    J Cardiovasc Pharmacol Ther; 2010 Mar 15; 15(1):24-30. PubMed ID: 20100903
    [Abstract] [Full Text] [Related]

  • 35. Long-term beta-blocker therapy improves diastolic function even without the therapeutic effect on systolic function in patients with reduced ejection fraction.
    Tamaki S, Sakata Y, Mano T, Ohtani T, Takeda Y, Kamimura D, Omori Y, Yamamoto K.
    J Cardiol; 2010 Sep 15; 56(2):176-82. PubMed ID: 20493661
    [Abstract] [Full Text] [Related]

  • 36. Improved left and right ventricular functions with trimetazidine in patients with heart failure: a tissue Doppler study.
    Gunes Y, Guntekin U, Tuncer M, Sahin M.
    Heart Vessels; 2009 Jul 15; 24(4):277-82. PubMed ID: 19626400
    [Abstract] [Full Text] [Related]

  • 37. Effect of Trimetazidine Dihydrochloride Therapy on Exercise Capacity in Patients With Nonobstructive Hypertrophic Cardiomyopathy: A Randomized Clinical Trial.
    Coats CJ, Pavlou M, Watkinson OT, Protonotarios A, Moss L, Hyland R, Rantell K, Pantazis AA, Tome M, McKenna WJ, Frenneaux MP, Omar R, Elliott PM.
    JAMA Cardiol; 2019 Mar 01; 4(3):230-235. PubMed ID: 30725091
    [Abstract] [Full Text] [Related]

  • 38. [Effect of combination therapy with preduktal and prestarium on the left ventricular function in the postinfarction period].
    Dzhindzholiia NR, Megreladze II.
    Georgian Med News; 2008 Feb 01; (155):20-3. PubMed ID: 18401050
    [Abstract] [Full Text] [Related]

  • 39. Comparison of resting energy expenditure in bronchopulmonary dysplasia to predicted equation.
    Bott L, Béghin L, Marichez C, Gottrand F.
    Eur J Clin Nutr; 2006 Nov 01; 60(11):1323-9. PubMed ID: 16804557
    [Abstract] [Full Text] [Related]

  • 40. Decreased rates of substrate oxidation ex vivo predict the onset of heart failure and contractile dysfunction in rats with pressure overload.
    Doenst T, Pytel G, Schrepper A, Amorim P, Färber G, Shingu Y, Mohr FW, Schwarzer M.
    Cardiovasc Res; 2010 Jun 01; 86(3):461-70. PubMed ID: 20035032
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 13.